Neurological Institute Outcomes

In 2020, 157 patients were treated with spine stereotactic radiosurgery, which is mainly used to treat malignant and metastatic tumors to the spine. Both the 30- and 180-day survival rates for these patients were 99% for 2020.

Functional status, as measured by the Karnofsky Performance Scale, remained stable or improved in 100% of patients after spine stereotactic radiosurgery. Change in status was defined as a change of ≥ 20 points.